Condensed Statements of Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Condensed Statements of Comprehensive Loss [Abstract]
Sales	$ 729,394	$ 554,908	$ 1,479,926	$ 1,047,532
Cost of sales (excluding depreciation expense)	293,838	190,839	569,275	352,496
Operating expenses:
Research and development	1,382,022	2,303,241	5,764,923	6,049,847
Sales and marketing	1,143,805	1,572,189	3,037,349	2,847,866
General and administrative	1,477,800	1,530,791	4,817,485	4,645,412
Depreciation and amortization	85,697	76,288	256,835	215,144
Total operating expenses	4,089,324	5,482,509	13,876,592	13,758,269
Loss from operations	(3,653,768)	(5,118,440)	(12,965,941)	(13,063,233)
Other (expense) income:
Interest income	17,315	124,028	53,488	532,850
Interest expense	(532,073)	(413,290)	(1,483,022)	(1,163,153)
Other expense	(26,295)	0	(286,295)	0
Total other expense, net	(541,053)	(289,262)	(1,715,829)	(630,303)
Loss before income taxes	(4,194,821)	(5,407,702)	(14,681,770)	(13,693,536)
Income tax expense (benefit)	0	1,158	(4,188)	(592)
Net loss	(4,194,821)	(5,408,860)	(14,677,582)	(13,692,944)
Net loss attributable to common stockholders, basic	(4,194,821)	(5,408,860)	(14,677,582)	(13,692,944)
Net loss attributable to common stockholders, diluted	$ (4,194,821)	$ (5,408,860)	$ (14,677,582)	$ (13,692,944)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.1)	$ (0.24)	$ (0.46)	$ (0.62)
Net loss per share attributable to common stockholders, diluted (in Dollars per share)	$ (0.1)	$ (0.24)	$ (0.46)	$ (0.62)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	41,015,196	22,232,799	31,739,828	22,075,135
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares)	41,015,196	22,232,799	31,739,828	22,075,135